Reference | Country / Jurisdiction | Design | Sample / Population | Outcome measures | PROS used | Intervention / Number of times feedback | Members of medical team given feedback | Management plan offered to team | Training to staff | Domain 1 | Domain 2 | Global Rating |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Trowbridge et al. (1997) [39] | USA (Central Indiana Community Cancer Centres, Indianapolis) | RCT: Intervention / Control | 320 cancer outpatients, 13 oncologists and 23 clinics | Pain Management Index(ref); pain medication level (0–3) minus pain level: Patient assessment of pain, pain regiments and relief received Patterns of analgesic prescription | Estimates of average and worst pain over the previous 7 days, satisfaction with current pain regimens and degree of relief received | One | Doctors only (12) | No | No | ** | *** | √√ |
Tazenzer et al. (2000) [33] | Canada (Tom Baker Cancer Centre , Calgary, Alberta) | Before-after trial: usual care group /Intervention group with before as control | 53 lung cancer patients attending an outpatient lung cancer clinic | EORTIC QLQ-C30 11-item Patient Satisfaction Questionnaire (PDIS) ( adapted through Falvo and Smith,1983) Exit Interview (patient’s perception if QL issues had been addressed during the visit) Medical Record Audit on patients’ care plan | EORTC QLQ-C30 (on a PC) | Once | Doctors and nurses | No | Ground round introduction and training | * | *** | √√ |
McLachlan et al. (2001) [38] | Australia (Peter MacCallum Cancer Centre, Melbourne) | RCT: Intervention /control (ratio: 2:1) | 450 cancer patients attending ambulatory clinics | Patient HRQoL (EORTC QLQ-C30) 32-item Patient needs (Cancer Needs Questionnaire Short Form [CNQ] Patient distress (Beck Depression Inventory (BDI) Patient satisfaction (in 6-month) Services provided for those identified as required by coordination nurse | EORTC QLQ-C30, CNQ, BDI (through a touch-screen PC) | One | Doctor and coordination nurse (numbers not reporter) | Individualised plan developed by coordination nurse in accordance with generic psychosocial guidelines | No | ** | *** | √√ |
Detmar et al. (2002) [37] | Netherland (Netherlands Cancer Institute, Amsterdam) | RCT: (Cross-over design) Intervention/control | 214 palliative cancer patients in a outpatient clinic of a cancer hospital | Patient-doctor communication Doctor’s awareness of patient HRQoL Patient management Patients’/doctors’ satisfaction Patient HRQoL (SF-36) Patients’/doctors’ evaluation of intervention | EORTC QLQ-30 | Three | Doctors (n=10) | No | Doctors given 30-mins training and patient mailed a leaflet | *** | **** | √√√ |
Mooney et al. (2002) [16] | USA (University of Utah, Salt Lake City, Utah) | A pilot Prospective study over a month period with daily measures | 27 patients receiving cancer chemotherapy at a cancer centre outpatient clinic | Telephone-Linked Care system for Chemotherapy (TLC-Chemo Alert) Seven symptoms (nausea and vomiting, fatigue, trouble sleeping, sore mouth, fever, feeling blue, feeling anxious) Exit interview | TLC-Chemo Alert | Patients asked to report daily during the cycle and the alerts were sent to providers | Doctors (n=2) | Yes | Patients trained (10 minutes TLC orientation) | ** | ** | √ |
Velikova et al. (2004) [36] | UK (Cancer Research UK Clinical Centre – Leeds) | RCT: Intervention /control-attention/control in a ratio of 2:1:1 | 286 cancer outpatients attending a large cancer centre of a teaching hospital | Patient HRQoL (FACT-G) Discussion of HRQoL issues in consultation Medical actions (decisions on cancer treatment, symptomatic/supportive treatment, investigations and referrals) Non-medical actions(advice on lifestyle, copying and reassurance) Physician checklist assessing the clinical usefulness of PROM data | EORTC QOQ-C30 Hospital Anxiety and Depression Scale (HADS) | Regular clinic visit over an average of 6 months | Doctor (n=28) | No | One to one training and manual provided | *** | **** | √√√ |
Basch et al. (2005) [41] | USA (Memorial Sloan-Kettering Cancer Center, New York) | Prospective pilot study of patient online self-reporting of toxicity symptoms | 80 patients diagnosed with a gynaecologic malignancy starting a new chemotherapy regimen | Pattern of use of a Self-reported online Symptom Track and Reporting (STAR) system Patient impression of such system based on an exit questionnaire survey Clinician feedback (through survey and team debriefing) | Symptom Track and Reporting (STAR) based on NCI CATAE system | Any clinic visits during 8-wk study period (mean=3, range 1–6) , also possible log in at home during the period | Doctors and study team (n=unreported) | Yes | Training provide to patients but unreported to staff | ** | ** | √ |
Boyes et al. (2006) [35] | Australia (Centre for Health Research & Psycho-oncology, University of Newcastle) | Pilot controlled trial: Intervention /control | 80 cancer outpatients attending one cancer centre | Patient symptoms Patient anxiety/depression(HADS) Patient needs (Supportive Care Needs Survey[SCNS] Acceptability of intervention to patient and doctors | Symptoms, HADS SCNS | 1st consultation – 100% patients: 2nd: 83%; 3rd: 71%; 4th: 60% | Doctors (n=4) | List of patients needs accompanied by suggestions for appropriate referral | None | ** | *** | √√ |
Hoeskstra et al. (2006) [42] | Netherlands (Academic Medical Centre, University of Amsterdam) | RCT: Intervention group with symptom monitoring / control | 146 palliative cancer patients recruited through two hospitals and local GPs | 10 symptoms from the Symptom Monitor Severity of the reported symptom (0–10 score) | Symptom Monitor Extensive Questionnaire | Weekly self-assessed Symptom Monitor at home; Extensive questionnaire every 2-month | GPs (98 times) and medical specialists(96 times) | No | No | ** | *** | √√ |
Korniblith et al. (2006) [43] | USA (Dana-Farber Cancer Institute, Boston) | RCT : Telephone Monitoring (TM) versus TM+Education Material (EM) | 192 cancer patients with advanced disease and receiving active treatment | EORTC-QLQ-30 HADS | EORTC-QLQ-30ǂ | Once a month over 6 months | Ontological nurses | Yes | Yes | *** | **** | √√√ |
HADS | ||||||||||||
MOS-SS | ||||||||||||
GDS (short form) | ||||||||||||
QARSQ-PH | ||||||||||||
UMPSI | ||||||||||||
GSRE | ||||||||||||
Patient Satisfaction with the Research Program BOMC test; | ||||||||||||
Basch et al. (2007) [44] | USA (Memorial Sloan-Kettering Cancer Center, New York) | Prospective pilot study of a patient online self-reporting of toxicity symptoms | 107 patients diagnosed with thoracic gynaecologic malignancy starting a new chemotherapy regimen | Feasibility/Pattern of use of a Self-reported online Symptom Track and Reporting (STAR) system Patient satisfaction survey (an exit questionnaire survey) Nursing survey (through an exit survey) | Symptom Track and Reporting (STAR) based on NCI CATAE system | Any clinic visits during 42-wk study period (mean=12, range 1–40) , also possible log in at home during the period | Nurses and study team (n=unreported) | No | Training provide to patients but unreported to staff | ** | ** | √ |
Rosenbloom et al. (2007) [34] | USA (Center on Outcomes, Research and Education, Evanston Northwestern Healthcare | RCT: Structured interview and discussion / assessment control / standard care | 213 patients with advanced breast, lung or colorectal cancer | Patient HRQoL (Functioning Living Index – Cancer [FLIC]) Patient affect (Brief Profile of Mood States [Brief POMS]) Patient satisfaction [PSQ-III] Clinical treatment changes as reported by nurse (supportive care changes, referrals, ‘other’ clinical changes and changes in standard dose of chemotherapy as a result of PROs) | FACT-G and a single item asking patients whether a particular symptom or problem was better than, worse than, or as expected | Clinic visits at baseline ,and 1, 2,3 and 6 months | Treating nurses (n=not reported) | No | No | *** | **** | √√√ |
Weaver et al. (2007) [45] | UK (Oxford Radcliffe Hospitals NHS Trust) | A pilot study of novel mobile phone technology | 6 colon cancer patients | Questionnaire on symptoms derived from the Common Terminology Criteria for Adverse Events (CTCAE) grading system | Questionnaire derived from the Common Terminology Criteria for Adverse Events (CTCAE) grading system | Twice daily during the chemotherapy circle (one morning, one evening) | Nurses (n= not reported) | Yes | Yes | ** | ** | √ |
Butt et al.(2008) [46] | USA (Center on Outcomes, Research and Education (CORE), Evanton Northwestern Healthcare) | Prospective study to explore the longitudinal screening and management of fatigue, pain, and emotional distress | 99 cancer patients with solid tumor of lymphoma undergoing cancer undergoing cancer treatment | FACT-G FACT-Fatigue subscale Brief Pain Inventory (BPI) HADS Structured interview with patients on HRQL and symptom management | FACT-G FACT-Fatigue subscale Brief Pain Inventory (BPI) HADS | Baseline, 1 month and 2 months after the baseline | Doctors and nurses | ? | ? | ** | ** | √ |
Given et al. (2008) [47] | USA( Michigan State University) | RCT: Nurse-Administrated Symptom Management (NASM) vs Automated Telephone Symptom Management (ATSM) intervention | 129 breast cancer patients | Outcomes measured at 10–16 wks: 15 symptoms (0–10 scale) Responses & Non-responses of symptoms Time to response | 15 symptoms (0–10 scale) Severity of the symptoms | 6 contacts or self-reporting (1–4 wk, 6wk, 8wk) | Nurses or ATSM system | Yes | Yes | ** | **** | √√√ |
Hilarius et al. (2008) [48] | Netherland (Hospital Pharmacy, Red Cross Hospital, Beverwijk) | A sequential cohort design with repeated measures to evaluate the use of HRQL assessments in daily clinical oncology nursing practice | 10 nurses and 219 patients cancer patients with either adjuvant or palliative chemotherapy in a community hospital | Dartmouth Primary Care Cooperative Information Functional Health Assessment (COOPcharts) Patient Management extracted from medical record Patient satisfaction (an exit survey based on PSQ, Form II) Patients’ self-reported HRQL (SF-36, FACT-BCS, FACT-C, FACT-L) Nurse and patient evaluation of the intervention (an exit survey) | EORTC QLQ-C30 EORTC QLQ-BR23 EORTC QLQ-CR38 EORTC QLQ-LC13 | Four consecutive visits after baseline for both pre (control arm) and post (intervention arm) with a two-month ‘wash-out’ period | Patients and nurses before consultations | No | Yes | *** | *** | √√ |
Mark et al. (2008) [49] | USA (Thomson Healthcare, Washington DC) | A cross-sectional survey of the of both patients’ and health professionals’ experience; A before-after patient chart review | 100 cancer patients and 92 health professionals on the experience of The Patient Assessment, Care and Education (PACE) System, including PCM instrument and an education component | Questionnaire survey of 102 providers The patients satisfaction survey (n=100) including 8-item on PCM 200 patient chart reviews (100 charts before and 100 charts after the PACE system) | PCM An education component (not reported in this study) | Each visit to clinic | Clinicians (n=unreported) | No | ? | ** | *** | √√ |
Kearney et al. (2009) [50] | UK (Cancer Care Research Centre, University of Stirling, Stirling) | RCT: Control group versus intervention group (mobile phone-based remote monitoring of symptoms) over five time points | 56 patients with lung, breast or colorectal cancer for each group (total 112 patients) | Paper version of electronic, Mobile phone-based Advanced Symptom Management Systems (ASyMS©) based on Common Toxicity Criteria Adverse Events (CTCAE) grading system and the Chemotherapy Symptom Assessment Scale | Mobile phone-based (ASyMS©) including chemotherapy-related morbidity of six common symptoms (nausea, vomiting, fatigue, mucositis, hand-foot syndrome and diarrhoea) | Five times including baseline and each of four chemotherapy cycles over a period of 14 days | Doctors only (n=unreported) | Yes | Yes | ** | **** | √√ |
Carlson et al. (2010) [51] | Canada (Tom Baker Cancer Centre, University of Calgary, Alberta) | RCT: minimum screening (distress) / full screening / Triage : full screening + referring to appropriate services | 585 breast cancer patients + 549 lung cancer patients | Patient distress at 3-month follow-up; Depression and anxiety at 3-month follow-up | Minimum screening: Distress thermometer (DT) Full screening: DT + Psychological scan for cancer part C (PSSCAN) | Baseline | Screening team member (n=unreported) | Yes | Yes | **** | **** | √√√ |
Dinkel et al. (2010) [52] | German (Department of Psychotherapy and Psychosomatic Medicine, Technische University Munchen) | Paired comparison : a computerised and a paper version of Stress Index Radio Oncology (SIRO) tool Prospective survey | 177 cancer patients in study 1, 273 cancer patients in study 2 (n=142 for computerised version and n=131 for paper version of SIRO) 27 Patients, urses/radiographs and 15 physicians evaluated the screening procedure | Agreement between computer and paper version of SIRO Patient satisfaction; Time need for both modes; Perceived utility; Perceived impact on communication; Perceived impact on patient outcome | SIRO | Any visit | Doctors and nurses (n=unreported) | No | No | *** | ** | √√ |
Halkett et al. (2010) [11] | Australian (WA Centre for Cancer and Palliative Care, Curtin University) | Pilot study of using computer touch-screen technology to asses psychological distress in patients | 60 patients with various gynaecological cancers | Patient satisfaction with both touch-screen and paper questionnaire; Perceived utility of both modes by patients and health professionals | EORTC QLQ-C30 HADS The Supportive Care Needs Scale The Distress Thermometer Follow questionnaire survey on perceived utility of both modes | Once | Nurses and doctors | Yes | Yes | * | ** | √ |
Ruland et al. (2011) [53] | Norway (Centre for Shared Decision Making and Nursing Research, Oslo University Hospital, Oslo) | RCT: a computer-assisted, interactive tailored assessment (ITPA) with feedback vs ITPA only in oncology practice | 145 patients treated for leukaemia or lymphoma | Number of patient symptoms and problems addressed Changes in symptom distress Changes in patients’ need for symptom management support over time, SF-36, Center for Epidemiological Studies Depression Scale (CES-D), Medical Outcome Study Social Support Scale (MOS – SS) | Choice ITPA(19 symptoms (0–4 scale on bothersome) and a severity scale of 0–10) | Every inpatient admission with up to four follow-up visits | Doctors and nurses (n=unreported) | No (as see appropriate) | Yes | *** | **** | √√√ |
Velikova et al. (2010) [54] | UK (Cancer Research UK Clinical Centre – Leeds) | RCT: Intervention/control-attention/control in a ratio of 2:1:1 | 286 cancer patients commencing treatment at the Medical Oncology Clinic at St James Hospital | Medical Care Questionnaire (MCQ): 15-item three subscales: Communication, Coordination, Patient preferences Satisfaction with care Patients’ and physicians’ evaluation of the intervention K-index (Continuity of care: K=(number of visits – number of doctors)/(number of visits −1). | EORTC QOQ-C30 Hospital Anxiety and Depression Scale (HADS) | Regular clinic visit over an average of 6 months | Doctor (n=28) | No | One to one training and manual provided | *** | **** | √√√ |
Bainbridge et al.(2011) [55] | Canada (Juravinski Cancer Centre, McMaster University, Hamilton, Ontario) | Survey on the utility of | 128 nurses, physicians, and allied health professionals | Perceptions of use and utility of the Edmonton Symptom Assessment System (ESAS) adopted by Ontario’s cancer centres since 2007 | ESAS | Every clinic visit | Doctors and nurses | Yes | Yes | * | * | √ |
Berry et al. (2011) [56] | USA (Dana-Faber Cancer Institute, Boston) | RCT: Intervention / Control | 660 cancer patients with various cancer diagnoses and stages at two institutions of a comprehensive cancer centre | 1.Audio-recorded content of all communication between clinicians, patients and accompanying friends or family members at each T2 visit (4–6 wks after the treatment) | Patient reported symptoms and quality-of-life (SQLIs) from the Electronic Self-Report Assessment-Cancer (ESRA-C) | Every clinic visit during the study period | Doctors (n=76 principle physicians and other) or incorporated into charts (n=unreported) | No | Yes | *** | **** | √√√ |
2.Clinic visit duration | ||||||||||||
3. Physician exit questionnaire survey | ||||||||||||
Cleeland et al. (2011) [20] | USA (MD Anderson Cancer Center, The University of Texas) | RCT: e-mail alert of symptom to patients’ clinical team versus no e-mail alert | 79 lung cancer patients receiving thoracotomy | 1. Four targeted symptom: pain, distress, disturbed sleep, and shortness of breath, constipation (no fatigue as no effective response) 2. MD Anderson Symptom Inventory (MDASI) at follow-up clinic visit 3. An exit questionnaire survey | Automated telephone calls (IVR system): MDASI (13 common cancer related symptoms) | Twice weekly, up to 4 wks after discharge | Nurses (n=unreported) | Yes | Training to patients provided | ** | **** | √√ |
Takeuchi et al. (2011) [57] | UK (St James’s Institute of Oncology, Leeds) | Longitudinal study of data as part of Velikova et al. (2004, 2010) RCT | 286 cancer patients commencing treatment at the Medical Oncology Clinic at St James Hospital | Audio-recorded content of Patient-physician communication: Longitudinal impact of PRO intervention; dynamics of communication; association between severity of symptoms/functions and clinic discussion | EORTC QOQ-C30 Hospital Anxiety and Depression Scale (HADS) | Four consecutive visits from baseline | Doctor (n=28) | No | One to one training and manual provided | *** | **** | √√√ |